-
Product Insights
Neuromuscular Disorders – Drugs In Development, 2023
Global Markets Direct’s, ‘Neuromuscular Disorders - Drugs In Development, 2023’, provides an overview of the Neuromuscular Disorders pipeline landscape. The report provides comprehensive information on the therapeutics under development for Neuromuscular Disorders, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) – Drugs In Development, 2023
Global Markets Direct’s, ‘Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) - Drugs In Development, 2023’, provides an overview of the Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the...
-
Product Insights
Gastrointestinal Tumor – Drugs In Development, 2023
Global Markets Direct’s, ‘Gastrointestinal Tumor - Drugs In Development, 2023’, provides an overview of the Gastrointestinal Tumor pipeline landscape. The report provides comprehensive information on the therapeutics under development for Gastrointestinal Tumor, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Company Profile
![]()
The Quaker Oats Co – Company Profile
The Quaker Oats Co (Quaker), a subsidiary of PepsiCo Inc, is a producer and marketer of oatmeal and snack foods. The company’s product portfolio includes hot cereals, cold cereals, snacks bars, rice snacks, ready-to-eat oat cereals, tortilla mixes, breakfast cookies, granola bites and instant grits. It provides barley, corn meal, mixes, cookies and biscuits, among others. The company operates its food manufacturing facility in Cedar Rapids, Iowa, the US. Quaker products are available globally. It sells its products through a...
Add to Basket -
Company Profile
![]()
Gruma SAB de CV – Company Profile
Gruma SAB de CV (Gruma) is a producer and distributor of corn flour and tortilla products. The company offers wheat flour, tortillas, flatbreads, commodities, sauces and dips, corn chips, and other related products. It also provides grits snacks and cereals, prepared flour, tortilla chips, pita bread, wraps, chapatti, naan, pizza bases, and other food products such as rice, pastas, snacks, palm hearts, and condiments. Gruma markets its products under the Mission, Maseca, Rumba, Fogon, Guerrero, Masa Rica, La Cima, and...
Add to Basket -
Company Profile
![]()
ePlus Inc – Company Profile
ePlus Inc (ePlus) is an information technology services provider. The company provides software solutions for cloud, data center, security, networking, collaborations, and artificial intelligence. It also offers consulting, professional and managed services, IT staff augmentation, and complete lifecycle management services including flexible financing and solutions. The company provides sales, pricing, credit, contracts, accounting, risk management, and asset management solutions. ePlus offers its products and services under the Where Technology Means More, OneSource, Viewmark, Docpak, GRIT, e+, IGXGlobal and ePlus brand...
Add to Basket -
Company Profile
![]()
The E. W. Scripps Co – Company Profile
The E. W. Scripps Co (Scripps) provides news, information and entertainment content, and advertising services. The company share news, information, and entertainment across an increasing number of media platforms. Scripps also offers advertising services to local, national, and political advertisers. It retransmits programmes to customers’ television sets, specialty set-top boxes, or computer or mobile devices. The company operates various news and entertainment networks including ION, Bounce, Court TV, Defy TV, Grit, ION Mystery, Laff, Newsy, and TrueReal. It owns and...
Add to Basket -
Company Profile
![]()
Tupy SA – Company Profile
Tupy SA (Tupy) is a manufacturer of engineered structural cast iron components. The company manufactures and commercializes engine blocks and heads, brake, transmission, axle, steering and suspension system parts, iron and steel grits, pipe fittings, and cast-iron bars. The company provides these products to various industries such as automotive, agriculture, construction, power generation and industrial sectors. The company has industrial plants and sales offices across Brazil, Portugal, Mexico, the US, Germany and Netherlands. Tupy is headquartered in Joinville, Santa Catarina,...
Add to Basket -
Product Insights
![]()
Ovarian Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Ovarian Cancer Pipeline Drugs Market Overview Ovarian cancer is any cancerous growth that may occur in different parts of the ovary. The majority of ovarian cancers arise from the epithelium (outer lining) of the ovary. Signs and symptoms of ovarian cancer include pelvic discomfort or pain, indigestion, gas or nausea, and changes in bowel habits, such as constipation, loss of appetite, and low back pain. The predisposing factors include age and family history. Treatment includes surgery, chemotherapy, and radiation therapy....
-
Product Insights
![]()
Non-Small Cell Lung Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Non-Small Cell Lung Cancer Pipeline Drugs Market Report Overview Non-small cell lung cancer (NSCLC) is the most common type of lung cancer. NSCLC (malignancy) originates in the tissues of the lungs or the cells lining the airways. Symptoms usually occur in the later stages of the disease, and include a persistent cough that may get worse over time, trouble breathing or shortness of breath, constant chest pain or discomfort, bloody phlegm or spit (sputum), fatigue and weakness, and unintentional weight...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.